TMS Co., Ltd. (TYO:4891)

Japan flag Japan · Delayed Price · Currency is JPY
131.00
-2.00 (-1.50%)
Apr 28, 2025, 3:30 PM JST
-44.49%
Market Cap 5.36B
Revenue (ttm) n/a
Net Income (ttm) -660.55M
Shares Out 40.33M
EPS (ttm) -16.38
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 824,700
Average Volume 1,009,135
Open 135.00
Previous Close 133.00
Day's Range 131.00 - 135.00
52-Week Range 120.00 - 314.00
Beta 0.17
RSI 33.01
Earnings Date Apr 11, 2025

About TMS Co., Ltd.

TMS Co., Ltd. engages in the research and development, manufacture, and sale of drug products, quasi-drugs, drug substances, medical devices, and medical commodities. The company is developing TMS-007, a stachybotrys microspora triprenyl phenol (SMTP) congener with prothrombolytic and anti-inflammatory/antioxidative activities, which has completed Phase 2a clinical trials for acute ischemic stroke treatment; and TMS-008, an SMTP congener with anti-inflammatory/antioxidative activities under nonclinical development for inflammatory complications... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2005
Employees 14
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4891
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.